CA
DBVT

Continuum Advisory’s DBV Technologies DBVT Stock Holding History

Continuum Advisory’s Portfolio DBVT Stock Details DBVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.56K Buy
+400
New +$7.55K ﹤0.01% 1397

Other funds holding DBVT

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

Continuum Advisory's DBVT Position: Q2 2026 in Review

Continuum Advisory opened a new position in DBV Technologies (DBVT) in Q2 2026: 400 shares worth $6.56K. The stake represents ﹤0.01% of the portfolio and ranks #1397 among its holdings.

78 funds tracked by Wall St. Rank hold DBVT as of Q2 2026.

  • Continuum Advisory held 400 shares of DBV Technologies worth $6.56K as of Q2 2026.
  • DBV Technologies was a new Continuum Advisory position in Q2 2026.
  • DBV Technologies made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1397 holding.
  • 78 funds tracked by Wall St. Rank held DBV Technologies as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.